BUZZ-India's Biocon gains on completing obligation under Viatris agreement** Shares of Biocon BION.NS rise 3.4% to 364.5 rupees
** Stock top gainer on Nifty Pharma Index .NIPHARM, which is up 0.54%
** BION said on Monday unit Biocon Biologics fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris
** Unit also completes full and final remittance of considerations toward Viatris
** 16 analysts covering the stock on avg have a "hold" rating; median PT is 334.5 rupees - LSEG data
** Stock up 46% YTD vs a 38% gain in NIPHARM
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments